Daiwa Securities Group Inc. - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 163 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$03720.0%0.00%
Q2 2022$0
-100.0%
3720.0%0.00%
Q1 2022$1,0000.0%3720.0%0.00%
Q4 2021$1,0000.0%3720.0%0.00%
Q3 2021$1,000
-50.0%
3720.0%0.00%
Q2 2021$2,000
+100.0%
3720.0%0.00%
Q1 2021$1,0000.0%3720.0%0.00%
Q4 2020$1,000
-50.0%
372
-54.1%
0.00%
Q3 2020$2,000
+100.0%
8100.0%0.00%
Q2 2020$1,0000.0%8100.0%0.00%
Q1 2020$1,000
-50.0%
8100.0%0.00%
Q4 2019$2,0000.0%8100.0%0.00%
Q3 2019$2,0000.0%8100.0%0.00%
Q2 2019$2,0000.0%8100.0%0.00%
Q1 2019$2,0000.0%8100.0%0.00%
Q4 2018$2,000
-33.3%
8100.0%0.00%
Q3 2018$3,000
+50.0%
8100.0%0.00%
Q2 2018$2,000
-33.3%
8100.0%0.00%
Q1 2018$3,0008100.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 9,105,691$30,140,0005.99%
Sio Capital Management, LLC 1,888,181$6,250,0003.50%
DAFNA Capital Management LLC 473,478$1,567,0001.32%
Cormorant Asset Management, LP 2,000,000$6,620,0000.96%
Ghost Tree Capital, LLC 1,100,000$3,641,0000.68%
Rhenman & Partners Asset Management AB 1,282,000$4,243,0000.67%
Palo Alto Investors LP 4,254,623$14,083,0000.67%
NEA Management Company, LLC 3,243,150$10,375,0000.36%
Telemetry Investments, L.L.C. 170,000$563,0000.25%
NJ State Employees Deferred Compensation Plan 355,000$1,175,0000.22%
View complete list of RIGEL PHARMACEUTICALS INC shareholders